Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ GCNT3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA532056
Description
Recommended positive controls: A549, H1299, HCT116. Predicted reactivity: Mouse (80%), Rat (80%), Rhesus Monkey (95%), Bovine (90%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This gene encodes a member of the N-acetylglucosaminyltransferase family. The encoded protein is a beta-6-N-acetylglucosamine-transferase that catalyzes the formation of core 2 and core 4 O-glycans on mucin-type glycoproteins.
Specifications
GCNT3 | |
Polyclonal | |
Unconjugated | |
GCNT3 | |
2010013H22Rik; 2210021I22Rik; 2210401J11Rik; Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3; beta1,6GlcNAc-transferase; beta-1,6-N-acetylglucosaminyltransferase; beta1,6-N-acetylglucosaminyltransferase-M; beta-16-N-acetylglucosaminyltransferase; C2/4GnT; C24GNT; C2GNT2; C2GNTM; C2GnT-M; C2GnT-mucin type; core 2 beta-1,6-N-acetylglucosaminyltransferase II; core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase; dI/C2/C4GnT; dIGnT; Gcnt3; glucosaminyl (N-acetyl) transferase 3, mucin type; GNTM; GnT-M; hC2GnT-M; mucus-type core 2 beta-1,6-N-acetylglucosaminyltransferase | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
9245 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
O95395 | |
GCNT3 | |
Recombinant fragment corresponding to a region within amino acids 10 and 261 of Human GCNT3. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction